ANRO
ALTO NEURO (ANRO)
NYSE
$18.97+$0.26 (+1.39%)
Price as of Jun 03, 2026 7:28 PM EDT
  • $704.3M
    Market Cap
  • 611.41%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
Research and Development Expense
-45.6M
-2.93%
-47.0M
N/A
Depreciation and Amortization Expense
661,000
+31.67%
502,000
N/A
Total Operating Expenses
66.4M
-3.27%
68.6M
N/A
Operating Profit
-66.4M
-3.27%
-68.6M
N/A
Interest Income
6.6M
-25.40%
8.9M
N/A
Interest Expense
-2.5M
+78.57%
-1.4M
N/A
Interest Income and Expense and Net
4.1M
-44.93%
7.5M
N/A
Total Nonoperating Income and Expense
3.1M
-56.46%
7.2M
N/A
Income before Taxes
-66.4M
-3.27%
-68.6M
N/A
Income Taxes
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
-63.2M
+2.94%
-61.4M
N/A
Net Income from Continuing Operations Applicable to Common
-63.2M
+2.94%
-61.4M
N/A
Basic EPS and Net Income
-2.19
-12.40%
-2.50
N/A
Diluted EPS and Net Income
-2.19
-12.40%
-2.50
N/A
Basic Weighted Average Shares
28.9M
+17.28%
24.6M
N/A
Diluted Weighted Average Shares
28.9M
+17.28%
24.6M
N/A
Balance Sheet
Cash and Cash Equivalents
176.5M
+4.91%
168.2M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
176.5M
+4.91%
168.2M
N/A
Total Current Assets
177.7M
+4.95%
169.3M
N/A
Accumulated Depreciation
1.5M
+51.99%
1.0M
N/A
Property and Plant and Equipment and Net
1.9M
-29.78%
2.7M
N/A
Total Long-Term Assets
338,000
+8,350.00%
4,000
N/A
Total Assets
184.7M
+4.03%
177.5M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
585,000
N/A
0
N/A
Total Current Liabilities
11.3M
+13.16%
10.0M
N/A
Total Long-Term Debt
18.4M
+59.19%
11.6M
N/A
Total Long-Term Liabilities
20.0M
+35.38%
14.8M
N/A
Total Liabilities
33.5M
+28.62%
26.1M
N/A
Retained Earnings
-201.6M
+45.69%
-138.4M
N/A
Total Stockholders Equity
151.1M
-0.21%
151.5M
N/A
Total Shares Outstanding
31.9M
+18.29%
27.0M
N/A
Cash Flow
Cash from Operating Activities
-51.8M
+9.16%
-47.4M
N/A
Capital Expenditures
24,000
-98.84%
2.1M
N/A
Cash from Investing Activities
-24,000
-98.84%
-2.1M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
60.1M
-55.72%
135.7M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
Return on Assets
-34.92%
N/A
N/A
N/A
Return on Equity
-41.80%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
Current Ratio
15.69
N/A
N/A
N/A
Cash Ratio
15.58
N/A
N/A
N/A
Debt-to-Equity Ratio
0.13
N/A
N/A
N/A
Debt-to-Assets Ratio
0.10
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow